Diogenx
Developer of a biotechnology platform designed to regenerate insulin-producing beta cells for the treatment of diabetes. The company offers recombinant proteins that modulate the signalling pathway, e...
Valuation
$21.2M
Latest known
Share Price
N/A
Total Raised
$41.5M
Last Round
N/A